Hip dislocation in cerebral palsy

BMJ

Volumn 332, Issue 7544, 2006, Pages 772-775

  Pountney, Teresa ^a   Green, Elizabeth M ^a  

^a Chailey Heritage Clinical Services   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BODY POSTURE; CEREBRAL PALSY; HIP DISLOCATION; HUMAN; REVIEW; ARTICLE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE COURSE; HIP SURGERY; OSTEOTOMY; PAIN ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; RADIOGRAPHY; SUBLUXATION; WALKING;

CEREBRAL PALSY; HIP DISLOCATION; HUMANS; POSTURE;

BACLOFEN; BOTULINUM TOXIN;

EID: 33645560043     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.332.7544.772     Document Type: Article

References (18)

1. Reimers J. The stability of the hip in children. A radiological study of the results of muscle surgery in cerebral palsy. Acta Orthop Scand Suppl 1980; 184: 1–100.
2. Scrutton D, Baird G. Surveillance measures of the hips of children with bilateral cerebral palsy. Arch Dis Child 1997; 56: 381–4.
3. Scrutton D, Baird G, Smeeton N. Hip dysplasia in bilateral cerebral palsy: incidence and natural history in children aged 18 months to 5 years. Dev Med Child Neurol 2001: 586–600.
4. Samilson RL, Tsou P, Aamoth G, Green WM. Dislocation and subluxation of the hip in cerebral palsy. J Bone Joint Surg Am 1972; 54A: 863–73.
5. Lonstein JE, Beck K. Hip dislocation and subluxation in cerebral palsy. J Pediatr Orthop 1986; 6: 521–6.
6. Boyd R, Dobson F, Parrott J, Love S, Oates J, Larson A, et al. The effect of botulinum toxin type A and a variable hip orthosis on gross motor function: a randomized controlled trial. Eur J Neurol 2001; 8: 109–19.
7. Barwood S, Baillieu C, Boyd R, Brereton K, Low J, Nattrass G, et al. Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial. Dev Med Child Neurol 2000; 42: 116–21.
8. Stott NS, Piedrahita L the American Academy of Cerebral Palsy and Developmental Medicine. Effects of surgical adductor releases for hip subluxation in cerebral palsy: an AACPDM evidence report. Dev Med Child Neurol 2004; 46: 628–45.
9. Hodgkinson I, Jindrich ML, Duhaut P, Vadot JP, Metton G, Berard C. Hip pain in 234 non-ambulatory adolescents and young adults with cerebral palsy: a cross-sectional multicentre study. Dev Med Child Neurol 2001; 43: 806–8.
10. Schwartz L, Engel JM, Jensen MP. Pain in persons with cerebral palsy. Arch Phys Med Rehabil 1999; 80: 1243–6.
11. Pountney TE, Mulcahy CM, Clarke S, Green EM. Chailey approach to postural management, 2nd ed. East Sussex: Chailey Heritage Clinical Services, 2004.
12. Brunner R, Baumannn JU. Long term effects of interthrochanteric varus-derotation osteotomy on femur and acetabulum in spastic cerebral palsy: an 11-18 year follow up study. J Pediatr Orthop 1997; 17: 585–91.
13. Hagglund G, Andersson A, Duppe H, Lauge-Pedersen H, Nordmark E, Westbom L. Prevention of hip dislocation of the hip in children with cerebral palsy. J Bone Joint Surg Br 2005; 87B: 95–101.
14. Pountney TE, Mandy A, Green EM, Gard P. Management of hip dislocation with postural management. Child Care Health Dev 2002; 28: 179–85.
15. Hankinson J, Morton RE. Use of a lying hip abduction system in children with bilateral cerebral palsy: a pilot study. Dev Med Child Neurol 2002; 44: 177–80.
16. Deleplanque B, Lagueny A, Flurin V, Arnaud C, Pedespan J-M, Fontan D, et al. Toxine botulinique dans la spasticite des adducteurs de hanche chez les enfants IMC et IMOC non marchants. Rev Chir Orthop Reparatrice Appar Mot 2002; 88: 279–85.
17. Fairhurst CBR. Analgesic effect of botulinum toxin (abstract). In: British Paediatric Neurology Association, 2004. London: MacKeith Press, 2004: 22.
18. Mall V, Heinen F, Kirschner J, Linder M, Stein S, Michaelis U, et al. Evaluation of botulinum toxin A therapy in children with adductor spasm by gross motor function measure. J Child Neurol 2000; 15: 214–7.